Palleon Pharmaceuticals
Palleon Pharmaceuticals is a glycoimmune Checkpoint Inhibitors founded in 2016.
2
Funding Rounds
$147.6m
Money raised
Overview
Palleon Pharmaceuticals is a glycoimmune Checkpoint Inhibitors founded in 2016.
-
Website:
- Business model: B2B
- Social accounts:
Industries
Palleon Pharmaceuticals is active in the following industries: